BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18379939)

  • 1. Intravitreal methotrexate resistance in a patient with primary intraocular lymphoma.
    Sen HN; Chan CC; Byrnes G; Fariss RN; Nussenblatt RB; Buggage RR
    Ocul Immunol Inflamm; 2008; 16(1):29-33. PubMed ID: 18379939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal methotrexate injections for intraocular involvement in primary central nervous system lymphoma.
    Tourville E; Tardif Y
    Can J Ophthalmol; 2003 Dec; 38(7):598-601. PubMed ID: 14740803
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.
    Frenkel S; Hendler K; Siegal T; Shalom E; Pe'er J
    Br J Ophthalmol; 2008 Mar; 92(3):383-8. PubMed ID: 18303160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Asian patient with intraocular lymphoma treated by intravitreal methotrexate.
    Wang JK; Yang CM; Lin CP; Shan YD; Lo AY; Tien HF
    Jpn J Ophthalmol; 2006; 50(5):474-478. PubMed ID: 17013703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two cases of primary intraocular lymphoma: fine needle aspiration diagnosis and intravitreal methotrexate treatment.
    Zhao T; Li Y; Tang L; Wei X; Zhu X
    J Huazhong Univ Sci Technolog Med Sci; 2011 Feb; 31(1):142-144. PubMed ID: 21336740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local methotrexate and dexamethasone phosphate for the treatment of recurrent primary intraocular lymphoma.
    Velez G; Boldt HC; Whitcup SM; Nussenblatt RB; Robinson MR
    Ophthalmic Surg Lasers; 2002; 33(4):329-33. PubMed ID: 12134997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement.
    Smith JR; Rosenbaum JT; Wilson DJ; Doolittle ND; Siegal T; Neuwelt EA; Pe'er J
    Ophthalmology; 2002 Sep; 109(9):1709-16. PubMed ID: 12208721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma.
    Velez G; Yuan P; Sung C; Tansey G; Reed GF; Chan CC; Nussenblatt RB; Robinson MR
    Arch Ophthalmol; 2001 Oct; 119(10):1518-24. PubMed ID: 11594954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of primary intraocular lymphoma treated by intravitreal methotrexate.
    Kim E; Kim C; Lee J; Cho Y
    Korean J Ophthalmol; 2009 Sep; 23(3):210-4. PubMed ID: 19794951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma.
    de Smet MD; Vancs VS; Kohler D; Solomon D; Chan CC
    Br J Ophthalmol; 1999 Apr; 83(4):448-51. PubMed ID: 10434868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary intraocular lymphoma invaded to the central nervous system after successful treatment with intraocular methotrexate injection].
    Watanabe K; Arai A; Takase H; Takahashi H; Iwanaga Y; Sugamoto Y; Sugita S; Mochizuki M; Miura O
    Rinsho Ketsueki; 2009 Mar; 50(3):182-6. PubMed ID: 19352085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal chemotherapy for recurrent central nervous system intraocular lymphoma.
    Mason JO; Fischer DH
    Ophthalmology; 2003 Jun; 110(6):1241-4. PubMed ID: 12799254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravitreal rituximab for the treatment of intraocular relapse of non-Hodgkin's lymphoma].
    Fernández Cañabate E; Fernández-Cañabate S
    Farm Hosp; 2018 Jan; 42(1):20-21. PubMed ID: 29306309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent administration of intravenous systemic and intravitreal methotrexate for intraocular lymphoma with central nervous system involvement.
    Nakauchi Y; Takase H; Sugita S; Mochizuki M; Shibata S; Ishiwata Y; Shibuya Y; Yasuhara M; Miura O; Arai A
    Int J Hematol; 2010 Jul; 92(1):179-85. PubMed ID: 20464643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma.
    Fishburne BC; Wilson DJ; Rosenbaum JT; Neuwelt EA
    Arch Ophthalmol; 1997 Sep; 115(9):1152-6. PubMed ID: 9298056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of intraocular lymphoma having retinal adverse events associated with intravitreal methotrexate].
    Kuroiwa N; Abematsu N; Matsuo Y; Nakao K; Sakamoto T
    Nippon Ganka Gakkai Zasshi; 2011 Jul; 115(7):611-6. PubMed ID: 21815491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eyewash with balanced salt solution after intravitreal methotrexate injection in a case of vitreoretinal lymphoma: a simple but effective way to prevent ocular surface toxicity.
    Moharana B; Parija S; Palanisamy S; Mishra P
    BMJ Case Rep; 2023 Jul; 16(7):. PubMed ID: 37474142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of primary intraocular lymphoma with intravitreal methotrexate.
    Sou R; Ohguro N; Maeda T; Saishin Y; Tano Y
    Jpn J Ophthalmol; 2008; 52(3):167-174. PubMed ID: 18661266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relapsed primary intraocular lymphoma treated with intravitreal methotrexate and high-dose chemotherapy followed by autologous stem cell rescue].
    Kamio T; Yokohama A; Hayashi T; Toyama K; Koya H; Hoshino T; Saitoh T; Hanyuda N; Mukai R; Handa H; Murakami H; Tsukamoto N; Nojima Y
    Rinsho Ketsueki; 2014 Feb; 55(2):244-8. PubMed ID: 24598193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusual presentation of cornea verticillata with intravitreal methotrexate in a case of primary intraocular lymphoma.
    Hasan N; Narde HK; Das AK; Chawla R
    BMJ Case Rep; 2022 Jan; 15(1):. PubMed ID: 35027386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.